The Centers for Disease Control and Prevention intends to award a sole-source, firm-fixed-price contract to Illumina for an Annual Maintenance Agreement for two Nextseq 1000 instruments. The period of performance is from January 31, 2026, through January 30, 2027. While this is a notice of intent for a non-competitive award, the government will consider expressions of interest or capability from other parties. Responses must be emailed to the specified Contract Specialist.